Imagine a world where athletes no longer have to fear the long-term consequences of repeated head impacts. It sounds like a dream, but a groundbreaking treatment might be on the horizon. Red light therapy, a seemingly unconventional approach, is showing promise in protecting athletes' brains from the cumulative damage caused by these impacts. But here's where it gets fascinating: this therapy doesn't just treat symptoms—it aims to prevent the damage before it even starts.
For decades, we’ve known that repeated blows to the head, even those that don’t cause immediate symptoms, can lead to serious long-term issues. Conditions like punch-drunk syndrome, boxer’s madness, and chronic traumatic encephalopathy (CTE) have haunted athletes, particularly in high-impact sports like football. Over 100 former NFL players have been posthumously diagnosed with CTE, a stark reminder of the risks involved. The symptoms—confusion, memory loss, and even dementia—are devastating, but what’s been even more frustrating is the lack of effective preventive measures.
And this is the part most people miss: even impacts that don’t directly affect the head can cause microscopic damage or trigger harmful processes that unfold over time. Current treatments for concussions and head injuries often focus on managing symptoms like headaches and balance issues, which can appear long after the initial injury. But what if we could stop the damage before it becomes irreversible?
Enter red light therapy. This innovative treatment involves shining powerful near-infrared light through the skull directly onto the brain. The idea is to reduce inflammation caused by repetitive impacts, which is believed to be a key driver of long-term brain damage. A preliminary study involving 26 collegiate football players suggests that this therapy could significantly protect their brains from inflammation over the course of a season. The results, published in the Journal of Neurotrauma, are nothing short of striking.
In the study, players were divided into two groups: one received red light therapy via a light-emitting headset and a nasal device, while the other received a placebo treatment. Both groups self-administered the therapy three times a week for 20 minutes per session throughout the 16-week season. The findings were remarkable. Players on the placebo treatment showed increased brain inflammation by the end of the season, as evidenced by MRI scans. In contrast, those who received red light therapy showed no such increase—their brains appeared protected from inflammation across almost all regions.
But here’s where it gets controversial: while the results are promising, the study’s small sample size raises questions about its broader applicability. Random chance led to different initial inflammation levels in the treatment and control groups, highlighting the need for larger, randomized clinical trials. Critics might argue that it’s too early to draw definitive conclusions, but proponents see this as a crucial first step toward a safer future for athletes.
The researchers themselves acknowledge the early stage of this therapy but remain optimistic. “When we first started this project, I was extremely skeptical,” admits Elisabeth Wilde, PhD, senior author of the study. “But the consistent results across multiple studies are starting to be quite compelling.” Her team is now launching a Department of Defense-funded trial involving 300 individuals with persistent symptoms from traumatic brain injuries (TBIs) or concussions, focusing on first responders, veterans, and active-duty service members. Recruitment is expected to begin in early 2026.
The potential implications are enormous. If red light therapy proves effective in larger trials, it could revolutionize how we protect athletes—and not just professionals. Carrie Esopenko, PhD, another researcher on the team, envisions a future where sports are safer for everyone, from kids to adults. “This feels like part of the hope for protecting the brain that we’ve been searching for,” she says.
But here’s a thought-provoking question for you: If red light therapy becomes widely adopted, could it change the way we approach sports safety? Would it encourage more people to participate in high-impact activities, or would it simply shift the focus to other potential risks? Let us know your thoughts in the comments below.
The study, titled ‘Transcranial Photobiomodulation Promotes Neurological Resilience in Current Collegiate American Football Players Exposed to Repetitive Head Acceleration Events,’ was supported by grants from Brigham Young University (BYU) and its affiliated departments. It’s worth noting that one of the researchers, Lawrence Carr, PhD, is a consultant for Vielight, Inc., the manufacturer of the devices used in the study—a detail that might spark further debate about potential conflicts of interest.
As we await more research, one thing is clear: red light therapy has the potential to be a game-changer in brain health. But the journey is just beginning, and the scientific community—along with athletes and their families—will be watching closely.
